FDA Cleared an AI Breast Cancer Risk Score. Here’s What’s Unproven
The FDA cleared TumorSight Risk, an AI tool that scores breast cancer recurrence from a routine MRI. Here's what it does and what's still unproven.
SimBioSys
Local weather
Finding your area…National Weather Service
Trending
- College Football Week 6 Guide: Georgia-Alabama, Red River and Every Big Game to Watch
- 42% More Completed Foreclosures, but Housing Isn’t at a Breaking Point
- India Shows Caller Names From Nov. 1. What It Means for Your Calls
- Meta, Tesla and SpaceX Face Wall Street’s Big AI Test After a Brutal Week
- FDA Cleared an AI Breast Cancer Risk Score. Here’s What’s Unproven